Search Results
Apr 26, 2026, 20:10 ET Ascletis Completes Enrollment in U.S. Phase II Study of ASC30, an Oral Small Molecule GLP-1R Agonist, for the Treatment of Diabetes
in participants with obesity or overweight, the Company expects to obtain the clearance from the U.S. Food and Drug Administration and initiate Phase III trials in the U.S. for obesity indication by the end of the third quarter 2026."ASC30 was discovered and developed
More news about: Ascletis Pharma Inc.
Apr 25, 2026, 12:30 ET Abbott showcases strength of its technologies to address abnormal heart rhythms with late-breaking clinical data at Heart Rhythm Society 2026
Society 2026, Chicago IL, USA.iii Reddy, V. (2026, April 25) LEAP2: A first-in-human study of a chronically-implanted novel leadless pacemaker for conduction system pacing [Late Breaking
More news about: Abbott
Apr 25, 2026, 03:05 ET Rosen Law Firm Encourages Immutep Ltd. Investors to Inquire About Securities Class Action Investigation - IMMP
this about: On March 13, 2026, Immutep issued a press release "announcing that the Independent Data Monitoring Committee (IDMC) for the TACTI-004 Phase III study evaluating eftilagimod alfa ('efti') in patients in 1(st) line non-small cell lung cancer has recommended the discontinuation of the trial following
More news about: THE ROSEN LAW FIRM, P. A.
Apr 24, 2026, 22:00 ET Soleno Therapeutics, Inc. Notice of May 5, 2026 Application Deadline for Class Action Lawsuit - Contact Lewis Kahn, Esq. at Kahn Swick & Foti, LLC, Before Application Deadline
result, the administration of DCCR to treat hyperphagia in individuals with PWS posed materially greater safety risks than disclosed by the Company; and (iii) consequently, DCCR had materially lower commercial viability and undisclosed risks related to the likelihood of significant and widespread adverse events
More news about: Kahn Swick & Foti, LLC
Apr 24, 2026, 22:00 ET Apollo Global Management, Inc. Securities Fraud Class Action Result of Undisclosed Relationship with Jeffrey Epstein and 16% Stock Decline - Investors may Contact Lewis Kahn, Esq, at Kahn Swick & Foti, LLC
regarding the Company's business; (ii) as a result, the Company's assertion that Apollo Global had never done business with Jeffrey Epstein was untrue; (iii) because of the entanglement between Apollo Global's leaders and Jeffrey Epstein, the harm to the Company's reputation was more than a mere possibility;
More news about: Kahn Swick & Foti, LLC
Apr 24, 2026, 22:00 ET Gemini Space Station, Inc. Notice of May 18, 2026 Application Deadline for Class Action Lawsuit - Contact Lewis Kahn, Esq. at Kahn Swick & Foti, LLC, Before Application Deadline
platform; (ii) the Company had overstated its commitment to and/or the viability of growing its business through expanding its international operations; (iii) accordingly, the Company's post-IPO financial and business prospects were overstated; (iv) all of the foregoing raised a non-speculative risk that the
More news about: Kahn Swick & Foti, LLC
Apr 24, 2026, 16:30 ET Citius Pharmaceuticals Announces Closing of Registered Direct Offering of $5 Million Priced At-The-Market Under Nasdaq Rules
Oncology. In December 2025, Citius Oncology launched LYMPHIR, a targeted immunotherapy for the treatment of adults with relapsed or refractory Stage I–III CTCL who had had at least one prior systemic therapy. Citius Pharma's late-stage pipeline also includes Mino-Lok®, a catheter lock solution
More news about: Citius Pharmaceuticals, Inc.
Apr 24, 2026, 16:25 ET Cerapedics Announces Supplier Agreement with Vizient for PearlMatrix® P-15 Peptide Enhanced Bone Graft
nation's largest provider-driven healthcare performance improvement company, for PearlMatrix® P-15 Peptide Enhanced Bone Graft, a Class III drug-device combination product for adult patients with degenerative disc disease in the lumbar spine. This agreement will offer enhanced access to the
More news about: Cerapedics Inc.
Apr 24, 2026, 16:00 ET Berlin Heals Presents Positive Late Breaking Results from the CMIC-III First-In-Human Less Invasive Study
data from the CMIC-III study show that we can achieve comparable improvements using a less invasive, outpatient procedure, significantly enhancing the safety profile and expanding access to a much broader population of patients."Berlin Heals has initiated Phase II of the CMIC-III less invasive FIH
More news about: Berlin Heals Holding AG
Apr 24, 2026, 16:00 ET Berlin Heals Presents Positive Late Breaking Results from the CMIC-III First-In-Human Less Invasive Study
data from the CMIC-III study show that we can achieve comparable improvements using a less invasive, outpatient procedure, significantly enhancing the safety profile and expanding access to a much broader population of patients."Berlin Heals has initiated Phase II of the CMIC-III less invasive FIH
More news about: Berlin Heals Holding AG
Apr 24, 2026, 11:12 ET Churchill Downs Racetrack, LG&E and KU Team Up Green Energy Partnership for 152nd Kentucky Derby
Exciting Two Minutes in Sports' and Kentucky Derby Week, which generate tremendous economic impact for our community and Kentucky," said John R. Crockett III, LG&E and KU President. "Through this unique partnership, we're demonstrating with Churchill Downs the flexibility of our customizable renewable
More news about: Louisville Gas and Electric and Kentucky Utilities
Apr 24, 2026, 08:38 ET The Jewelers Board of Trade Holds Annual Elections
two years are:Ms. Lika Behmoaras, ISC Industries, Inc. d/b/a Lika Behar Collection, Carlstadt, NJRoger H. Gesswein, III, Paul H. Gesswein & Co., Bridgeport, CTKeven Peck, Color Merchants, Inc., New York, NYAdditionally, re-elected to the
More news about: The Jewelers Board of Trade
Apr 24, 2026, 08:00 ET Citius Pharmaceuticals Announces a Registered Direct Offering of $5 Million Priced At-The-Market Under Nasdaq Rules
Oncology. In December 2025, Citius Oncology launched LYMPHIR, a targeted immunotherapy for the treatment of adults with relapsed or refractory Stage I–III CTCL who had had at least one prior systemic therapy. Citius Pharma's late-stage pipeline also includes Mino-Lok®, a catheter lock solution
More news about: Citius Pharmaceuticals, Inc.
Apr 24, 2026, 08:00 ET Norfolk Southern reports first quarter 2026 results
impacting the transportation industry; (ii) the Company's ability to successfully implement its operational, productivity, and strategic initiatives; (iii) a significant adverse event on our network, including but not limited to a mainline accident, discharge of hazardous material, or climate-related or
More news about: Norfolk Southern Corporation
Apr 24, 2026, 07:03 ET WuXi Biologics Chengdu Microbial Commercial Manufacturing Site Achieves Structural Completion and Key Equipment Arrival
operations, and more efficient manufacturing. As of December 31, 2025, WuXi Biologics is supporting 945 integrated client projects, including 74 in Phase III and 25 in commercial manufacturing, with complex modalities representing more than half of the entire project portfolio.WuXi Biologics regards
More news about: WuXi Biologics
Apr 24, 2026, 07:00 ET Charter Announces First Quarter 2026 Results
to or when they become due and to fund our operations and necessary capital expenditures, either through (i) cash on hand, (ii) free cash flow, or (iii) access to the capital or credit markets;our ability to comply with all covenants in our indentures and credit facilities, any violation of
More news about: Charter Communications, Inc.
Apr 24, 2026, 05:00 ET VNET Publishes 2025 Environmental, Social and Governance Report
consecutive year; (ii) Awarded a "B" rating on the 2025 CDP Climate Change Questionnaire, with nine out of 16 categories achieving A-grade recognition; (iii) Received a "low risk" ESG Risk Rating from Sustainalytics.To view the full 2025 ESG Report, please visit the Company's Investor Relations
More news about: VNET Group, Inc.
Apr 23, 2026, 20:06 ET UPST Stockholders Have Rights - If You Lost Money Investing in Upstart Holdings, Inc. Contact Robbins LLP for Information About Recovering Your Losses
risk-separationprocesses; (ii) accordingly, Model 22's overall accuracy and propensity to increase loan approvalrates were overstated; and (iii) Model 22's overly conservative assessment of credit and macroeconomic conditions was having a significant negative impact on Upstart's revenue results,
More news about: Robbins LLP
Apr 23, 2026, 17:21 ET NEW Episode: The White House 1600 Sessions Podcast "America's 250th: American Artists in the Royal Collection"
landscapes."I think George III had a soft spot for the Americans and that one of his great sadnesses, was that the colonies were lost in his reign," said Knox. "We know that with resumption of diplomatic ties he treated the envoy with great respect and cordiality, so I think George III would be very pleased
More news about: The White House Historical Association
Apr 23, 2026, 16:45 ET RICHMOND MUTUAL BANCORPORATION, INC. ANNOUNCES 2026 FIRST QUARTER FINANCIAL RESULTS
Company, (ii) statements about the Company's plans, objectives, expectations, and intentions and other statements that are not historical facts, and (iii) other statements identified by the words or phrases "will likely result," "are expected to," "will continue," "is anticipated," "estimate," "project,"
More news about: Richmond Mutual Bancorporation, Inc.
Apr 23, 2026, 16:35 ET EAGLE FINANCIAL SERVICES, INC. ANNOUNCES 2026 FIRST QUARTER FINANCIAL RESULTS AND QUARTERLY DIVIDEND
requirements, Bank of Clarke must maintain a capital conservation buffer of additional capital of 2.5 percent of risk-weighted assets as required by the Basel III capital rules. The Bank of Clarke exceeded these ratios at March 31, 2026.Explanation of Non-GAAP Financial Measures This release
More news about: Eagle Financial Services, Inc.
Apr 23, 2026, 16:15 ET First Financial Bancorp Announces First Quarter 2026 Financial Results
our future operating or financial performance, including revenues, income or loss and earnings or loss per share, (ii) future common stock dividends, (iii) our capital structure, including future capital levels, (iv) our plans, objectives and strategies, and (v) the assumptions that underlie our forward-looking
More news about: First Financial Bancorp.
Apr 23, 2026, 16:15 ET Associated Banc-Corp Reports First Quarter 2026 Net Income Available to Common Equity of $117 Million, or $0.70 per Common Share
capital position remains strong, with a CET1 capital ratio of 10.47% at March 31, 2026. The Company's capital ratios continue to be in excess of the Basel III "well-capitalized" regulatory benchmarks on a fully phased in basis.FIRST QUARTER 2026 EARNINGS RELEASE CONFERENCE CALLThe Company
More news about: Associated Banc-Corp
Apr 23, 2026, 16:01 ET South Atlantic Bancshares, Inc. Reports Earnings of $0.58 per Diluted Common Share for the Quarter Ended March 31, 2026
conditions, and any regulatory responses thereto; (ii) slower economic growth rates or potential recession in the United States and our market areas; (iii) uncertainty or perceived instability in the banking industry as a whole; (iv) increased competition for deposits among traditional and nontraditional
More news about: South Atlantic Bank
Apr 23, 2026, 16:01 ET COLUMBIA BANKING SYSTEM, INC. REPORTS FIRST QUARTER 2026 RESULTS
savings and any revenue or expense synergies from the Transaction may not be fully realized or may take longer than anticipated to be realized, and (iii) deposit attrition, customer or employee loss, and/or revenue loss as a result of the Transaction; the impact of proposed or imposed tariffs by the U.S.
More news about: Columbia Banking System, Inc.